Gorka Fius
Chief Executive Officer at Dreavent, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Leo Walter | M | - |
Dreavent, Inc.
 Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | - |
| Kevin J. Heyeck | M | - |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | - |
| Antonin Rollet de Fougerolles | M | 59 |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | - |
| Wendy Nelson | M | - |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | 1 years |
| Afshin Safavi | M | - |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | - |
| William S. Korinek | M | - |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | - |
| Fius Gorka/chimeron Bio/ | - | - |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | - |
| Jeff Miller | M | - |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | 1 years |
| PETER CHOO | M | - |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | - |
| STEFANO DE SOCIO | M | - |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Julian Adams | M | 69 |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 6 years |
| Christopher Haqq | M | 58 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 4 years |
| Jaime Mayor de Juan | M | - |
Artá Capital SGEIC SA
 Artá Capital SGEIC SA Investment ManagersFinance Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain. | 2 years |
| Pablo Torralbo Rodríguez | M | - |
Artá Capital SGEIC SA
Artá Capital SGEIC SA Investment ManagersFinance Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain. | 3 years |
| Peter DeMuth | M | 38 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 6 years |
| Kevin Siver | M | - |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 14 | 87.50% |
| Spain | 2 | 12.50% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gorka Fius
- Personal Network
